SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-20-177618
Filing Date
2020-06-24
Accepted
2020-06-24 16:02:33
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d948820d424b5.htm 424B5 589557
2 GRAPHIC g948820g46w53.jpg GRAPHIC 47816
3 GRAPHIC g948820g74n27.jpg GRAPHIC 46421
  Complete submission text file 0001193125-20-177618.txt   716082
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Filer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-233061 | Film No.: 20985499
SIC: 2834 Pharmaceutical Preparations